Article Text
Featured editorial
Percutaneous coronary revascularisation: is it ever worth what it costs?
Statistics from Altmetric.com
Footnotes
Conflict of interest:
Consulting: All <10k
Aventis, Bridgewater, New Jersey, USA
AstraZeneca, London, UK
Medtronic, Inc., Minneapolis, Minnesota, USA
Novartis, East Hanover, New Jersey, USA
Research Grants: All >10k
National Institutes of Health/National Heart, Lung, and Blood Institute
National Institutes of Health/Agency for Healthcare Research and Quality
Proctor & Gamble, Cincinnati, Ohio, USA
Pfizer, New York City, New York, USA
Medtronic, Inc., Minneapolis, Minnesota, USA
Alexion Pharmaceuticals, Inc., Cheshire, Connecticut, USA
Medicure, Winnipeg, Manitoba, Canada
Miscellaneous: >10k
Mosby, St. Louis, Missouri, USA, American Heart Journal Editor
- Abbreviations:
- ACS
- acute coronary syndrome(s)
- CAD
- coronary artery disease
- MI
- myocardial infarction
- PCI
- percutaneous coronary intervention, QALY, quality-adjusted life year